资讯

The Institute of Cancer Research, London, is one of the world's most influential cancer research organisations, with an outstanding record of achievement.
Scientists discover how to remove skin cancer’s protective armour and stop it spreadingThe goal of our laboratory is to improve the treatment and survival of children with neuroblastoma, ...
Our leadership teamProfessor Kristian Helin Chief Executive and President The Chief Executive is responsible to the Board of Trustees for the overall direction of the ICR’s management, research and ...
Our research excellence The Institute of Cancer Research, London, is the second-ranked academic research centre in the UK - according to the Times Higher Education league table of university research ...
Centre for Cancer Drug Discovery The Centre for Cancer Drug Discovery at The Institute of Cancer Research, London, is the largest academic cancer drug discovery and development group worldwide. Its ...
The Adult Drug Development Unit (DDU) and The Royal Marsden NHS Foundation Trust, is a group focused on early anti-cancer drug development.
The courses provide the necessary physics background that underpins day-to-day medical imaging physics activities.
Improving access to clinical trials Clinical trials are the single best way to turn advances in science into patient benefits. The ICR has a vision that a suitable trial should be made available for ...
Give a monthly donation to help us stay one step ahead of cancer with new smarter and targeted treatments – so that more people will survive blood cancer. Cecelia Brunott (pictured above) was ...
This two day course aims to improve understanding of MRIgRT, focusing on the knowledge and skills required to support current and future needs in radiotherapy.
The Institute of Cancer Research, London, is one of the world's most influential cancer research organisations, with an outstanding record of achievement.
Paediatric Solid Tumour Biology and Therapeutics Group Professor Louis Chesler’s group is investigating the genetic causes for the childhood cancers, neuroblastoma, medulloblastoma and ...